Download PDF
Neuropediatrics 2007; 38(4): 167-172
DOI: 10.1055/s-2007-990266
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

High-Dose Vitamin D Supplementation in Children with Cerebral Palsy or Neuromuscular Disorder

P. Kilpinen-Loisa 1 , H. Nenonen 2 , H. Pihko 3 , O. Mäkitie 4
  • 1Päijät-Häme Central Hospital, Department of Pediatric Neurology, Lahti, Finland
  • 2Ruskeasuo School, Developmental Center for the Disabled, Helsinki, Finland
  • 3Pediatric Neurology, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
  • 4Metabolic Bone Diseases, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
Further Information

Publication History

received 19.03.2007

accepted 07.08.2007

Publication Date:
04 December 2007 (online)

    Permissions and Reprints

Abstract

Adequate vitamin D levels are essential for normal skeletal development and mineralization. This is particularly important in children with cerebral palsy or other neuromuscular disorders who are at an increased risk of osteoporosis. The aim of this study was to evaluate the effect of high-dose vitamin D3 supplementation on vitamin D status in 44 disabled children. Vitamin D was administered during school days (1000 IU vitamin D3 per orally five days per week for 10 weeks) to half of the children (N=21) while the others (N=23) continued without supplementation. At baseline the median serum 25-hydroxyvitamin D was 44 nmol/L (range 26-82 nmol/L). The concentration increased significantly during the 10 weeks intervention in the supplemented group (median 56 nmol/L, range 39-88 nmol/L; p=0.012 for the difference from baseline) and decreased in the control group (median 37 nmol/L, range 24-74 nmol/L; p=0.038). No significant changes in any of the other measured parameters were observed. Hypovitaminosis D is prevalent in disabled children. Supplementation with 1000 IU vitamin D3 perorally five days per week results in a significant increase in vitamin D level and is not associated with hypercalcemia or other adverse effects.

Key words

osteoporosis - parathyroid hormone - hypovitaminosis D - bone turnover

References

  • 1 Baker MR, MacDonnell H, Peacock M, Nordin BE. Plasma 25-hydroxyvitamin D concentrations in patients with fracture of the femoral neck.  BMJ. 1979;  1 589
    PubMedGoogle Scholar
  • 2 Bischoff-Ferrari HA, Dawson -Hughes B, Willet WC, Staehelin HB, Bazemore MG, Zee RY. et al . Effect of vitamin D on falls: a meta-analysis.  JAMA. 2004;  291 1999-2006
    CrossrefPubMedGoogle Scholar
  • 3 Bischoff-Ferrari HA, Dietrich T, Orav JE, Hu FB, Zhang Y, Karlson EW. et al . Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >or=60 y.  Am J Clin Nutr. 2004;  80 752-758
    PubMedGoogle Scholar
  • 4 Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.  Am J Clin Nutr. 2004;  80 ((suppl)) S1717-1720
    PubMedGoogle Scholar
  • 5 Chapuy M, Arlot M, Duboeuf F, Brun J, Crouzet B, Arnaud S. et al . Vitamin D3 and calcium to prevent hip fractures in the elderly women.  New Engl J Med. 1992;  327 1637-1642
    CrossrefPubMedGoogle Scholar
  • 6 Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S. et al . Prevalence of vitamin D insufficiency in adult normal population.  Osteoporos Int. 1997;  7 439-443
    CrossrefPubMedGoogle Scholar
  • 7 Cheng S, Tylavsky F, Kröger H, Kärkkäinen M, Lyytikäinen A, Koistinen A. et al . Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls.  Am J Clin Nutr. 2003;  78 485-492
    PubMedGoogle Scholar
  • 8 Crofton P, Wade J, Taylor M, Holland C. Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in school children.  Clin Chem. 1997;  43 1577-1581
    PubMedGoogle Scholar
  • 9 Davies M, Adams P. The continuing risk of vitamin D intoxication.  Lancet. 1978;  2 621-623
    PubMedGoogle Scholar
  • 10 Dawson-Hughes B, Heaney R, Holick M, Lips P, Meunier P, Vieth R. Estimates of optimal vitamin D status.  Osteoporosis Int. 2005;  16 713-716
    CrossrefPubMedGoogle Scholar
  • 11 Docio S, Riancho JA, Perez A, Olmos JM, Amado J, Gonzales-Macias J. Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies.  J Bone Miner Res. 1998;  13 544-548
    CrossrefPubMedGoogle Scholar
  • 12 Finnish Nutrition Recommendations . , Committee report 1998: 7. National Nutrition Council, Nutrition Recommendation Section, Ministry of Agriculture and Forestry, Helsinki, Finland
  • 13 Fitzpatrick L. Pathophysiology of bone loss in patients receiving anticonvulsant therapy.  Epilepsy et Behav. 2004;  5 S3-15
    PubMedGoogle Scholar
  • 14 Gertner J, Domenach M. 25-hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol.  Clin Pathol. 1977;  30 144-150
    CrossrefPubMedGoogle Scholar
  • 15 Glerup H, Eriksen EF. Muscle and falls. In: Feldman D, Pike JW, Glorieux F. Vitamin D (eds.), 2nd edn., Amsterdam, the Netherlands: Elsevier Inc 2005: 1805-1820
    Google Scholar
  • 16 Guillemant J, Taupin P, Le HT, Taright N, Allemandou A, Peres G. et al . Vitamin D status during puberty in French healthy male adolescents.  Osteoporos Int. 1999;  10 222-225
    CrossrefPubMedGoogle Scholar
  • 17 Heanney R. Functional indices of vitamin D status and ramifications of vitamin D deficiency.  Am J Clin Nutr. 2004;  80 1706S-1709S
    PubMedGoogle Scholar
  • 18 Henderson RC. Vitamin D levels in noninstitutionalized children with cerebral palsy.  J Child Neurol. 1997;  12 443-447
    CrossrefPubMedGoogle Scholar
  • 19 Henderson R. Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia.  Dev Med Child Neurol. 1997;  39 224-227
    PubMedGoogle Scholar
  • 20 Henderson R, Lark R, Gurka M, Worley G, Fung E, Conaway M. et al . Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy.  Pediatrics. 2002;  , Available from: http://www.pediatrics.org/cg1/content/full/110/1/e
    PubMedGoogle Scholar
  • 21 Jackson R, LaCroix A, Grass M, Wallace R, Robbins J, Lewis C. et al . Calcium plus vitamin D supplementation and the risk of fractures.  NEJM. 2006;  354 669-683
    CrossrefPubMedGoogle Scholar
  • 22 Kauppinen-Mäkelin R, Tähtelä R, Löyttyniemi E, Kärkkäinen J, Välimäki MJ. A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients.  J Intern Med. 2001;  249 559-563
    CrossrefPubMedGoogle Scholar
  • 23 Keren R, Zaoutis TE, Bridges CB, Herrera G, Watson BM, Wheeler AB. et al . Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection.  JAMA. 2005;  294 2188-2194
    CrossrefPubMedGoogle Scholar
  • 24 Khaw K-T, Sneyd M-J, Compston J. Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women.  BMJ. 1992;  305 273-277
    PubMedGoogle Scholar
  • 25 King W, Levin R, Schmidt R, Oestreich A, Heubi J. Prevalence of reduced bone mass in children and adults with spastic quadriplegia.  Dev Med Child Neurol. 2003;  45 12-16
    PubMedGoogle Scholar
  • 26 Lamberg-Allardt CJ, Outila TA, Kärkkäinen MU, Rita HJ, Valsta LM. Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe?.  J Bone Miner Res. 2001;  16 2066-2073
    PubMedGoogle Scholar
  • 27 Larson C, Henderson R. Bone mineral density and fractures in boys with Duchenne muscular dystrophy.  J Ped Orthopaed. 2000;  20 71-74
    PubMedGoogle Scholar
  • 28 LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.  JAMA. 1999;  281 1505-1511
    CrossrefPubMedGoogle Scholar
  • 29 Lehtonen-Veromaa M, Möttönen T, Irjala K, Kärkkäinen M, Lamberg-Allardt C, Hakola P. et al . Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15 year-old Finnish girls.  Eur J Clin Nutr. 1999;  53 746-751
    CrossrefPubMedGoogle Scholar
  • 30 Lehtonen-Veromaa M, MöttönenT, Nuotio I, Irjala K, Leino A, Viikari J. Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study.  Am J Clin Nutr. 2002;  76 1446-1453
    PubMedGoogle Scholar
  • 31 Leonard M, Zemel B. Current concepts in pediatric bone disease.  Pediatr Clin North Am. 2002;  49 143-173
    CrossrefPubMedGoogle Scholar
  • 32 Lips P, Duong T Oleksik A, Black D, Cummings S, Cox D. et al . A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.  J Clin Endocrinol Metab. 2001;  86 1212-1221
    CrossrefPubMedGoogle Scholar
  • 33 Mawer E, Hann J, Berry J, Davies M. Vitamin D metabolism in patients intoxicated with ergocalciferol.  Clin Sci. 1985;  68 135-141
    PubMedGoogle Scholar
  • 34 Palisano R, Rosenbaum P, Walter S, Russel D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy.  Dev Med Child Neurol. 1997;  39 214-223
    CrossrefPubMedGoogle Scholar
  • 35 Panitch HB. Viral respiratory infections in children with technology dependence and neuromuscular disorders.  Pediatr Infect Dis J. 2004;  23 S222-227
    PubMedGoogle Scholar
  • 36 Parfitt AM. Osteomalacia and related disorders. In: Metabolic Bone Diseases San Diego, CA, USA: Academic Press 1991: 329-396
  • 37 Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases.  Eur J Clin Invest. 2005;  35 290-304
    CrossrefPubMedGoogle Scholar
  • 38 Quan A, Adams R, Ekmark E, Baum M. Bone mineral density in children with myelomeningocele.  Pediatrics. 1998;  , Available from: http://www.pediatrics.org/cgi/content/full/102/3/e34
    PubMedGoogle Scholar
  • 39 Rizzoli R, Stoermann C, Amman P, Bonjour J-P. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy.  Bone. 1994;  15 193-198
    CrossrefPubMedGoogle Scholar
  • 40 Sheth RD. Bone health in pediatric epilepsy.  Epilepsy et Behav. 2004;  5 S30-35
    PubMedGoogle Scholar
  • 41 Sluis van der I, Muinck Keizer-Schrama S. Osteoporosis in childhood: Bone density of children in health and disease.  J Ped Endocrin Metab. 2001;  14 817-832
    PubMedGoogle Scholar
  • 42 Sochett EB, Mäkitie O. Osteoporosis in chronically ill children.  Ann Med. 2005;  37 286-294
    PubMedGoogle Scholar
  • 43 Steelman J, Zeitler P. Osteoporosis in pediatrics.  Pediatr Rev. 2001;  22 56-65
    PubMedGoogle Scholar
  • 44 Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake.  JAMA. 2005;  294 2336-2341
    CrossrefPubMedGoogle Scholar
  • 45 Thomas M, Lloyd-Jones D, Thadhani R, Shaw A, Deraska D, Kitch B. et al . Hypovitaminosis D in medical inpatients.  N Engl J Med. 1998;  338 777-783
    CrossrefPubMedGoogle Scholar
  • 46 Turpeinen U, Hohenthal U, Stenman U. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay.  Clin Chem. 2003;  49 1521-1523
    CrossrefPubMedGoogle Scholar
  • 47 Tähtelä R, Turpeinen M, Sorva R, Karonen S-L. The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects.  Clin Biochem. 1997;  30 35-40
    PubMedGoogle Scholar
  • 48 Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.  Am J Clin Nutr. 1999;  69 842-856
    CrossrefPubMedGoogle Scholar
  • 49 Viljakainen H, Palssa A, Kärkkäinen M, Jakobsen J, Cashman K, Moelgaard C, Lamberg-Allardt. A seasonal variation of calcitropic hormones, bone turnover and bone mineral density in early and mid-puberty girls-a cross-sectional study.  Br J Nutr. 2006;  96 124-130
    CrossrefPubMedGoogle Scholar

Correspondence

P. Kilpinen-LoisaMD 

Department of Pediatric Neurology

Päijät-Häme Central Hospital

Keskussairaalankatu 7

15850 Lahti

Finland

Phone: +358/3/81 91 1

Fax: +358/3/81 92 973

Email: paivi.kilpinen-loisa@phsotey.fi

      >